MONTREAL, CANADA: BioAmber Inc (BIOA) has commenced an underwritten public offering of its Series A units, with each Series A unit consisting of one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to purchase one share of common stock.
The company is also offering Series B units, in lieu of Series A units, to those purchasers whose purchase of additional Series A units in the offering would result in the purchaser beneficially owning more than 4.99 percent of the Company's outstanding common stock following the offering, if they so choose.
The Series B units will consist of pre-funded warrants to purchase one share of common stock, Series A warrants to purchase one share of common stock and Series B warrants to purchase one share of common stock.
HC Wainwright & Co is acting as the sole book-running manager for the offering.
No comments:
Post a Comment